## 2026 H1 / 9M trading and change programme progress
- Strong H1 2026 results and 9M 2026 trading updates showed continued premium growth, margin improvement and delivery from the company-wide change programme.
- A new Group Chief Marketing and Revenue Officer role was created, with Aparna Sarin appointed in July 2026.
- Investors treated Hiscox as a scaling, margin-improving specialist underwriter with active capital returns and disciplined underwriting. The change programme reinforced a "growth with efficiency" narrative and supported confidence in medium-term targets.
- Insurance contract written premium for H1 2026 was $3,238.4m.
- Insurance service result for H1 2026 was $255.4m.
- Adjusted operating profit before tax for H1 2026 was $331.0m.
- Adjusted operating return on tangible equity (ROTE) was 20.2%.
- The interim dividend was 16.8¢ per share.
2025 — record underwriting and investment year; change programme progressing
FY 2025 preliminary and full-year results reported record profit before tax, record underwriting and investment results, and progress on the multi-year change programme.
Market perception shifted toward Hiscox as a high-returning specialist insurer executing both top-line growth and margin expansion. Investor focus moved to sustaining underwriting discipline, deploying capital through dividends and buybacks, and delivering change-programme savings.
Profit before tax for FY 2025 was $732.7m.
Insurance service result reached a record $613.9m.
The undiscounted combined ratio was 87.8%, the best in a decade.
The change programme delivered a P&L benefit of $29m in 2025, with target benefits rising thereafter.
FY 2025 ROTE was approximately 20.9%, as referenced in earnings commentary.
2024 — sustained underwriting strength under IFRS 17 transition
Reporting for 2024 and early 2025 reflected continued profitable underwriting across Retail, London Market and Re.
Preparation and reporting under IFRS 17 affected comparatives and presentation.
Investors increasingly viewed Hiscox as delivering consistent underwriting improvement and capital generation. The IFRS 17 transition clarified insurance-service performance and reinforced credibility in combined-ratio improvements.
The undiscounted group combined ratio improved into the high-80s range by 2024–2025, per later reporting.
The FY 2024 insurance service result and profit contributed to the 2025 record.
2023 — leadership change and resilient results through active catastrophe year
Jonathan Bloomer was appointed Independent Non-Executive Chair, effective 1 July 2023.
Hiscox delivered strong 2023 preliminary results despite an active catastrophe year.
Market emphasis was on the governance refresh and on evidence that the diversified specialist model could absorb catastrophe volatility while returning meaningful profit. Investor confidence benefited from reserve resilience and capital metrics.
Profit before tax for FY 2023 was $625.9m.
Insurance service result was $492.3m.
Net investment result was $384.4m.
The undiscounted combined ratio was 89.8%.
Net asset value per share was 951.1¢.
The Bermuda solvency capital ratio was 212%.
2022 — volatile investment result, continued reserve strengthening and LPT activity
FY 2022 results showed modest profit before tax, with volatility from investment losses.
Hiscox continued to use loss portfolio transfers (LPTs) to manage tail risk, and positive prior-year reserve development continued.
Investors saw Hiscox executing deliberate de-risking and reserve management while facing macro-driven investment headwinds. The stock narrative held that underwriting momentum and reserve strength could offset investment volatility.
Profit before tax for FY 2022 was approximately $44.7m.
The combined ratio was 90.6%.
Positive reserve development was $239m.
The margin above the actuarial estimate fell to 8.9%, from 11.7% in 2021.
Additional LPTs completed in 2022 reinsured 23% of 2019 and prior gross reserves.
2021 — post-pandemic recovery, reserve releases and restored profitability
FY 2021 preliminary results showed a return to profit after pandemic losses, driven by positive prior-year reserve development and favourable non-catastrophe loss experience.
Hiscox executed LPTs to transfer older reserve tail risk.
Investor perception moved from pandemic-era uncertainty toward a resilience and recovery story. Profitable underwriting, reserve strengthening and proactive reinsurance were cited as evidence that the balanced strategy had restored returns and de-risked capital.
Profit before tax for FY 2021 was $190.8m, against a FY 2020 loss of $(268.5)m.
Gross premiums written were $4,269.2m.
Net premiums earned were $2,919.9m.
The combined ratio was 93.2%.
Net asset value per share was 739.8¢.
Positive prior-year development was $148.9m.
LPTs reinsured 15% of 2019 and prior gross reserves, according to company disclosure.
Key Points
From recommendation (November 16, 2026)
Gross written premiums in the first nine months of 2026 rose 9.5% to US$4.437 billion (up 8.1% on a currency-adjusted basis). According to the research, the combined ratio stood at 90.4%.
Retail grew 9.1% on a currency-adjusted basis to USD 2.25 billion, with double-digit growth in the third quarter; the full-year target of 9% has been confirmed.
Investment result falls to US$104.2 million (prior year: US$350.8 million), with the investment return dropping to 1.2% from 4.2%
Buyback program of over US$300 million 81% completed as of October 30
AM Best affirmed the Financial Strength Rating of A (Excellent) on November 6, with a stable outlook.
Valuation at a P/E of 8.7 and a P/B of 2.1 is moderate, given a return on equity of 16.5%.
Investment Thesis
From recommendation (November 16, 2026)
Hiscox is deliberately shifting growth toward retail, where specialist expertise and brand reputation support pricing better than in the large-volume markets. The nine-month figures show this clearly: double-digit premium growth in the third quarter, confirmed targets, and an ongoing cost programme expected to contribute 75 million US dollars to earnings in 2026. At the same time, reinsurance pricing is coming down from its peak levels, and investment income is delivering noticeably less than a year earlier. The picture is therefore operationally solid, but not without headwinds. What remains interesting is whether underwriting, the share buyback and the cost programme can offset the weaker investment contribution by the full-year results on 24 February 2027.
Key risks and downside factors
Hiscox is a UK-listed specialist insurer focused on specialty commercial lines, small-business and high-net-worth personal insurance, with material exposure to the Lloyd's market. Its competitors include global specialty insurers and large multi-line carriers that compete on underwriting scale, distribution and reinsurance capacity. The main risks are underwriting and catastrophe losses, volatility in reinsurance and capital costs, competitive pressure from larger diversified insurers and insurtech entrants, and regulatory and corporate governance developments in the UK and the Lloyd's market.
Concentration in property, liability and specialty lines can produce highly variable combined ratios and capital strain after major events.
Reinsurance and capital cost risk: when reinsurance prices rise or available capacity shrinks, insurers retain more of their own exposure. This can force larger reserve strengthening or leave them with less competitive pricing.
Competitive pressure and margin compression: larger global insurers, Lloyd's peers and nimble insurtechs can undercut pricing or win distribution, eroding Hiscox's underwriting margins and growth.
Regulatory, rating, and Lloyd's market governance risk: changes in UK or Lloyd's regulation, solvency requirements, or credit rating downgrades would raise capital costs and constrain underwriting capacity.
Competitive landscape
Hiscox is a UK-listed specialist insurer focused on specialty commercial lines, small-business and high-net-worth personal insurance, with material exposure to the Lloyd's market. Its competitors include global specialty insurers and large multi-line carriers that compete on underwriting scale, distribution and reinsurance capacity. The main risks are underwriting and catastrophe losses, volatility in reinsurance and capital costs, competitive pressure from larger diversified insurers and insurtech entrants, and regulatory and corporate governance developments in the UK and the Lloyd's market.
Full-year figures for the fiscal year, to be published on 24 February 2027
Completion of the USD 300 million share repurchase
Implementation of the USD 75 million earnings contribution from the 2026 transformation program
Retail Growth in the Year-End Push Against the 9% Target
Development of Reinsurance Prices and Natural Catastrophe Losses
Interest rate environment and recovery in capital investment returns
Analysis
From recommendation (November 16, 2026)
The business model is broader than the name suggests: Retail, London Market, and Re & ILS serve different types of demand. Professional indemnity and cyber cover for SMEs and self-employed professionals are often effectively indispensable, either because contracts require them or because a single uninsured loss could be existential. For art, kidnap and ransom, and high-value home policies, cover is formally optional, but the need among the customers they target is clear. This fits the current numbers, in which Retail sets the pace.
Since 2022, management under CEO Aki Hussain has delivered disciplined capital allocation, a restructured US digital business, and higher distributions. The buyback is 81% complete, and the refinancing of the 2027 bond with a new 5.875% bond due 2031 looks well organised. AM Best confirms this with a very strong balance sheet assessment and a stable outlook. The track record is good but not spotless, as the COVID disputes and legacy issues in the US retail business are part of the history.
The downsides lie in competition and the cycle. In the London Market, particularly property business, and in Re & ILS, capital and capacity are interchangeable. Hiscox Re's prices fell 14% over nine months but still sit roughly 55% above their 2018 level. Net retained premiums declined 7.5%, which suggests Hiscox prefers to stay cautious here. In the US cyber market, competition is clearly intensifying, and experience alone does not guarantee success.
There is also the investment side. Unrealised bond losses of USD 192.2 million pushed the yield down to 1.2%, though management expects these to unwind as the bonds mature. On valuation, the P/E and P/B ratios look moderate, but the PEG of 3.65 is a reminder that earnings growth cannot be extrapolated indefinitely. In short, the quality is solid, but the company carries catastrophe and interest rate risk with it.
Performance Figures of Hiscox Ltd
in GBX
1M High / Low
2006.65 / 1790.00
52W High / Low
2006.65 / 1288.00
5Y High / Low
2006.65 / 769.40
1M
+5.71%
3M
+8.25%
6M
+7.74%
1Y
+49.71%
3Y
+108.60%
5Y
+160.46%
Relative Performance vs Benchmarks
Period
Hiscox Ltd
vs DAX
vs S&P 500 (SPY)
1M
+5.71%
+4.00%
+10.76%
3M
+8.25%
+9.78%
+12.65%
6M
+7.74%
+4.33%
+9.31%
1Y
+49.71%
+38.60%
+38.32%
3Y
+108.60%
+46.75%
+41.92%
5Y
+160.46%
+101.20%
+93.95%
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
Period
P/E Ratio
P/S Ratio
P/B Ratio
P/CF Ratio
Current
8.6
1.0
2.1
9.5
1Y ago
6.9
1.1
1.6
73.0
3Y ago
5.3
0.8
1.3
18.6
5Y ago
55.9
0.9
1.6
-175.8
Frequently Asked Questions
From recommendation (November 16, 2026)
Is Hiscox Ltd a good investment?
Hiscox Ltd has a Leeway Score of 37.8/100, which is rated as Fair. The Leeway Score combines business quality, fundamental evaluation, and valuation cycle into a comprehensive assessment. A higher score indicates stronger investment quality based on AI-powered fundamental analysis.
What does Hiscox Ltd do?
Hiscox Ltd is a company characterized by the following investment thesis: Hiscox Ltd, through its subsidiaries, provides insurance and reinsurance services in the United Kingdom, Europe, the United States, and internationally. It operates through Hiscox Retail, Hiscox London Market, and Hiscox Re segments. The company offers commercial insurance, such as emerging professions, media and tech, and small business insurance; and personal lines, including high-value homes and fine art, as well as artwork, antiques, classic cars, jewelry, collectables, and other assets through brokers, partners, and direct-to-consumers. It also provides property insurance; marine, specialty, cyber, and energy insurance; casualty insurance; terrorism, kidnap, and ransom insurance; and other specialty insurance products. In addition, the company offers property and casualty reinsurance services, as well as investment services. Hiscox Ltd was founded in 1901 and is headquartered in Pembroke, Bermuda. Hiscox Ltd operates in the Financial Services / Insurance - Property & Casualty industry is based in UK employs around 3,000 people. Hiscox Ltd recently reported revenue of about 4.12B GBX, a profit margin of 15.57%, return on equity of 16.51%, a market capitalisation around 6.19B GBX, valuation multiples of roughly 14x earnings, 1.5x sales, 2.1x book value. Analyst consensus currently expects earnings per share of around 2.06 GBX with year‑over‑year growth of 22.61%. Hiscox Ltd has an ongoing dividend policy and pays around 0.53 GBX per share (2.70% yield).
What are the key metrics for HSX.LSE?
Key metrics for HSX.LSE include valuation (P/E 8.7, P/S 1, P/B 2.1), profitability (profit margin 15.57%, ROE 16.51%), and growth (revenue 5.00%, earnings 22.00%). Market capitalization is 612.51B GBX. These metrics give an overview of the company's financial performance and valuation.
How has Hiscox Ltd's stock price performed?
Hiscox Ltd's stock has returned – over 1 year, – over 3 years, and – over 5 years. Performance can vary depending on market conditions and company developments.
How is HSX.LSE valued?
HSX.LSE has the following valuation metrics: P/E Ratio: 8.7, P/S Ratio: 1, P/B Ratio: 2.1. These metrics help assess whether the stock is fairly valued compared to its fundamentals.
What are the growth catalysts for Hiscox Ltd?
The key growth catalysts for Hiscox Ltd are:
Full-year figures for the fiscal year, to be published on 24 February 2027
Completion of the USD 300 million share repurchase
Implementation of the USD 75 million earnings contribution from the 2026 transformation program
Retail Growth in the Year-End Push Against the 9% Target
Development of Reinsurance Prices and Natural Catastrophe Losses
Interest rate environment and recovery in capital investment returns
These factors can positively influence the company's future growth and performance.
What are the key risks when investing in HSX.LSE?
Key risks for HSX.LSE include: Hiscox is a UK-listed specialist insurer focused on specialty commercial lines, small-business and high-net-worth personal insurance, with material exposure to the Lloyd's market. Its competitors include global specialty insurers and large multi-line carriers that compete on underwriting scale, distribution and reinsurance capacity. The main risks are underwriting and catastrophe losses, volatility in reinsurance and capital costs, competitive pressure from larger diversified insurers and insurtech entrants, and regulatory and corporate governance developments in the UK and the Lloyd's market.
Concentration in property, liability and specialty lines can produce highly variable combined ratios and capital strain after major events.
Reinsurance and capital cost risk: when reinsurance prices rise or available capacity shrinks, insurers retain more of their own exposure. This can force larger reserve strengthening or leave them with less competitive pricing.
Competitive pressure and margin compression: larger global insurers, Lloyd's peers and nimble insurtechs can undercut pricing or win distribution, eroding Hiscox's underwriting margins and growth.
Regulatory, rating, and Lloyd's market governance risk: changes in UK or Lloyd's regulation, solvency requirements, or credit rating downgrades would raise capital costs and constrain underwriting capacity.
Investors should consider these risk factors carefully before making an investment decision.
Who are the main competitors of Hiscox Ltd?
Hiscox Ltd competes with several listed peers in its sector. Hiscox is a UK-listed specialist insurer focused on specialty commercial lines, small-business and high-net-worth personal insurance, with material exposure to the Lloyd's market. Its competitors include global specialty insurers and large multi-line carriers that compete on underwriting scale, distribution and reinsurance capacity. The main risks are underwriting and catastrophe losses, volatility in reinsurance and capital costs, competitive pressure from larger diversified insurers and insurtech entrants, and regulatory and corporate governance developments in the UK and the Lloyd's market.
Admiral Group (ADM.LSE)
Direct Line Insurance Group (DLG.LSE)
Hastings Group Holdings (HSTG.LSE)
These competitors influence pricing power, growth opportunities and relative valuation.
When does Hiscox Ltd report earnings?
Hiscox Ltd's next earnings report date is February 24, 2027.
Key Metrics
From recommendation (November 16, 2026)
Market Capitalization
612.51B GBX
P/E Ratio
8.66
Analyst Target Price
2043.79 GBP
Valuation Metrics
P/S Ratio
1.02
P/B Ratio
2.14
Profitability Metrics
Profit Margin
15.57%
Operating Margin
18.41%
Return on Equity
16.51%
Return on Assets
3.84%
Growth Metrics
Revenue Growth
5.00%
Earnings Growth
22.00%
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
Year
Dividend
Yield at payment
Avg. yield
2026
0.12 GBP
0.69%
1.2%
2026
0.27 GBP
1.67%
2025
0.11 GBP
0.81%
2025
0.22 GBP
1.91%
2024
0.10 GBP
0.85%
2024
0.20 GBP
1.61%
2023
0.10 GBP
0.97%
2023
0.19 GBP
1.63%
2022
0.10 GBP
1.12%
2022
0.18 GBP
1.91%
2021
0.08 GBP
0.87%
2019
0.11 GBP
0.71%
2019
0.23 GBP
1.40%
2018
0.10 GBP
0.62%
2018
0.20 GBP
1.30%
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
37.5%
Beat estimate
62.5%
Miss estimate
+79.7%
Avg surprise when beat
-78.26%
Avg surprise when miss
Reports analyzed: 24
Upcoming earnings report
February 24, 2027
Next earnings date
Analyst estimates for upcoming periods
Next year
December 31, 2027
Consensus2.06
Range1.81 – 2.20
9 analysts
Est. growth vs prior: 22.61%
Revisions: 7d ↑2 ↓0 · 30d ↑6 ↓1
Next quarter
March 31, 2025
n/a
Key financial figures
All figures in USD
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.